| __timestamp | Insmed Incorporated | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 31073000 | 381287000 |
| Thursday, January 1, 2015 | 43216000 | 452612000 |
| Friday, January 1, 2016 | 50679000 | 316800000 |
| Sunday, January 1, 2017 | 79171000 | 330100000 |
| Monday, January 1, 2018 | 168218000 | 265800000 |
| Tuesday, January 1, 2019 | 210796000 | 336200000 |
| Wednesday, January 1, 2020 | 203613000 | 423900000 |
| Friday, January 1, 2021 | 234273000 | 467000000 |
| Saturday, January 1, 2022 | 265784000 | 487000000 |
| Sunday, January 1, 2023 | 344501000 | 477100000 |
Igniting the spark of knowledge
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of United Therapeutics Corporation and Insmed Incorporated from 2014 to 2023. Over this period, United Therapeutics consistently outspent Insmed, with SG&A expenses peaking at approximately 487 million in 2022, a 28% increase from 2014. In contrast, Insmed's expenses grew more dramatically, surging by over 1,000% from 31 million in 2014 to 345 million in 2023. This stark difference highlights United Therapeutics' stable financial strategy compared to Insmed's aggressive expansion. Such insights are invaluable for investors and analysts seeking to understand the financial health and strategic priorities of these companies.
Gilead Sciences, Inc. vs United Therapeutics Corporation: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of United Therapeutics Corporation and Genmab A/S
United Therapeutics Corporation and Bio-Techne Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Catalyst Pharmaceuticals, Inc.
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
United Therapeutics Corporation vs Vericel Corporation: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Insmed Incorporated or Amneal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for Insmed Incorporated and Vericel Corporation
Who Optimizes SG&A Costs Better? Insmed Incorporated or Supernus Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Iovance Biotherapeutics, Inc.